{
    "Trade/Device Name(s)": [
        "Nova Max Mini Blood Glucose and \u03b2-Ketone Monitor System",
        "Nova Max Mini Blood Glucose Test Strips",
        "Nova Max Mini Ketone Test Strips",
        "Nova Max Mini Glucose/Ketone Control Solutions"
    ],
    "Submitter Information": "Nova Biomedical Corporation",
    "510(k) Number": "K122688",
    "Predicate Device Reference 510(k) Number(s)": [
        "K091547",
        "K112638",
        "K101633"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJY",
        "JIN"
    ],
    "Summary Letter Date": "April 4, 2013",
    "Summary Letter Received Date": "March 25, 2013",
    "Submission Date": "March 22, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660",
        "21 CFR 862.1435"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Quality control (assayed and unassayed)",
        "Ketone test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "tdm"
    ],
    "Analyte(s)": [
        "Glucose",
        "\u03b2-hydroxybutyrate (\u03b2-ketone)"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [
        "Test strip"
    ],
    "Instrument(s)/Platform(s)": [
        "Nova Max Mini Blood Glucose and \u03b2-Ketone Monitor"
    ],
    "Method(s)/Technology(ies)": [
        "Coulometric electrochemical sensor"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Control Solution",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for Nova Max Mini Blood Glucose and \u03b2-Ketone Monitor System for quantitative measurement of glucose and \u03b2-hydroxybutyrate in capillary whole blood for diabetes self-management.",
    "Indications for Use Summary": "Intended for single-patient home use by individuals with diabetes mellitus for quantitative measurement of glucose or \u03b2-hydroxybutyrate in fresh capillary whole blood; not intended for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}